Stockreport

ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
PDF Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in Q3Selected triple-negative breast can [Read more]